Clinical and Biological Characteristics of Hidradenitis Suppurativa
ConditionHidradenitis Suppurativa
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age13+
SponsorUniversity of California, San Francisco
About this trial
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 13 years or older
Diagnosis of HS clinically-confirmed by a physician
Disqualifiers
No history of chronic skin conditions
No recent history of antibiotic use
Trial population
Patients with Hidradenitis Suppurativa
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
1,000 Participants
are grouped into 2 trial groupsGroup A: Hidradenitis Suppurativa Patients
Group B: Healthy Volunteers
Trial outcomes
Primary outcomes
1
The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa.
Time frame
2016-2026Secondary outcomes
1
Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy.
Time frame
2016-2026Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov